Clinical Trials Browser

Phase 2 × Breast Cancer Metastatic × 30 days × Clear all

NCT06750484 2026-02-27

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Phase 2 Recruiting

Breast Cancer Metastatic

NCT04059484 2026-02-24

AMEERA-3

Phase 2 Terminated

367 enrolled 30 charts

Breast Cancer Metastatic